Hörl WH - Search Results

1

Prospective randomised cross-over comparison of three LDL-apheresis systems in statin pretreated patients with familial hypercholesterolaemia.

Schmaldienst S, Banyai S, Stulnig TM, Heinz G, Jansen M, Hörl WH, Derfler K. Schmaldienst S, et al. Among authors: horl wh. Atherosclerosis. 2000 Aug;151(2):493-9. doi: 10.1016/s0021-9150(99)00398-6. Atherosclerosis. 2000. PMID: 10924726 Clinical Trial.

2

Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia.

Goldammer A, Wiltschnig S, Heinz G, Jansen M, Stulnig T, Hörl WH, Derfler K. Goldammer A, et al. Among authors: horl wh. Metabolism. 2002 Aug;51(8):976-80. doi: 10.1053/meta.2002.34016. Metabolism. 2002. PMID: 12145769

3

Direct adsorption of lipoproteins (DALI) from whole blood: first long-term clinical experience with a new LDL-apheresis system for the treatment of familial hypercholesterolaemia.

Jansen M, Banyai S, Schmaldienst S, Goldammer A, Rohac M, Hörl WH, Derfler K. Jansen M, et al. Among authors: horl wh. Wien Klin Wochenschr. 2000 Jan 28;112(2):61-9. Wien Klin Wochenschr. 2000. PMID: 10703153

4

Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.

Biesenbach P, Schmaldienst S, Smolen JS, Hörl WH, Derfler K, Stummvoll GH. Biesenbach P, et al. Among authors: horl wh. Atheroscler Suppl. 2009 Dec 29;10(5):114-21. doi: 10.1016/S1567-5688(09)71824-0. Atheroscler Suppl. 2009. PMID: 20129388

5

Regression of coronary atherosclerosis and amelioration of renal function during LDL-immunoadsorption therapy in a renal transplant recipient.

Jansen M, Gabriel H, Banyai S, Pidlich J, Weidinger F, Hörl WH, Derfler K. Jansen M, et al. Among authors: horl wh. Wien Klin Wochenschr. 1996;108(14):425-31. Wien Klin Wochenschr. 1996. PMID: 8784984

6

Immunoadsorption and plasma exchange in pregnancy.

Dittrich E, Schmaldienst S, Langer M, Jansen M, Hörl WH, Derfler K. Dittrich E, et al. Among authors: horl wh. Kidney Blood Press Res. 2002;25(4):232-9. doi: 10.1159/000066343. Kidney Blood Press Res. 2002. PMID: 12424425

7

Lipoprotein pattern in end-stage renal disease and following successful renal transplantation.

Banyai-Falger S, Gottsauner-Wolf M, Stepan E, Strobl W, Jansen M, Heinz G, Hörl WH, Derfler K. Banyai-Falger S, et al. Among authors: horl wh. Clin Transplant. 1997 Dec;11(6):545-51. Clin Transplant. 1997. PMID: 9408682

8

Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis.

Banyai S, Streicher J, Strobl W, Gabriel H, Gottsauner-Wolf M, Rohac M, Weidinger F, Hörl WH, Derfler K. Banyai S, et al. Among authors: horl wh. Metabolism. 1998 Sep;47(9):1058-64. doi: 10.1016/s0026-0495(98)90278-5. Metabolism. 1998. PMID: 9751233

9

Up-regulation of LDL-receptor expression by LDL-immunoapheresis in patients with familial hypercholesterolemia.

Streicher J, Valent P, Schmidt H, Sengölge G, Wagner O, Strobl W, Hörl WH, Derfler K. Streicher J, et al. Among authors: horl wh. J Investig Med. 1999 Sep;47(8):378-87. J Investig Med. 1999. PMID: 10510590

10

Low density lipoprotein immunoapheresis does not increase plasma lipid peroxidation products in vivo.

Kostner K, Banyai S, Jansen M, Khoschsorur G, Hörl WH, Maurer G, Winklhofer-Roob B, Derfler K. Kostner K, et al. Among authors: horl wh. Clin Chim Acta. 1999 Oct;288(1-2):21-30. doi: 10.1016/s0009-8981(99)00087-x. Clin Chim Acta. 1999. PMID: 10529454

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters